Healthcare | April 17, 2022
Signia launches its first hearing impairment store in Delhi
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
A team of experts at Fortis Gurugram conducted 3-dimensional mapping with the help of the new system Carto version 7 to precisely map the source of the arrhythmia. It was detected that the arrhythmia was coming from the conduction system i.e. body’s natural wiring.
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
It strengthens its presence to over 250 stores
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
The study was conducted in patients with mild to moderate COVID-19
Subscribe To Our Newsletter & Stay Updated
